Durolane Compared to Saline in Patients With Unilateral Knee Osteoarthritis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

218 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This was a study that compared Durolane injections to saline injections in the treatment of unilateral osteoarthritis of the knee. The patients were randomly assigned one of the two treatments unaware of which treatment they received. The study was conducted at 13 centers in Germany, the United Kingdom and Sweden. Patients were followed for six weeks after study treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Durolane Versus Methylprednisolone in Knee Osteoarthritis

NCT01209364

Knee Osteoarthritis

COMPLETED PHASE3

Different Volumes of Durolane in Knee OA

NCT01265459

Knee Osteoarthritis

COMPLETED PHASE2

Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis

NCT01753830

Knee Osteoarthritis

TERMINATED NA

Gait Patterns After Intraarticular Treatment of Patients With Osteoarthritis of the Knee

NCT00731289

Osteoarthritis

COMPLETED PHASE4

Knee OsteoArthritis Long-term Assessment

NCT06839222

Knee Osteoarthritis (Knee OA)

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Unilateral Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Durolane injection

Intraarticular injection of 3 ml Durolane.

Group Type ACTIVE_COMPARATOR

Durolane injection

Intervention Type DEVICE

Saline injection

Intraarticular injection of physiological sodium chloride (0.9% NaCl) solution pH 7.

Group Type PLACEBO_COMPARATOR

Saline injection

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Durolane injection

Intervention Type DEVICE

Saline injection

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Osteoarthritis according to ACR (American College of Radiology) criteria for the knee
* WOMAC pain score in the range 7 to 17
* Significant knee pain for the majority of days during the past 3 months
* Patient normally active, not bedridden or confined to a wheelchair and able to walk 50 meters without the help of a walker, crutches or a cane
* Patient has attempted but not responded adequately to non-pharmacological therapy(ies)
* Patient co-operative and able to communicate effectively with the investigators
* Signed informed consent obtained

Exclusion Criteria

* Bilateral knee osteoarthritis
* Osteoarthritis or clinically significant pain from other part of the musculoskeletal system than the study knee
* Kellgren Lawrence radiographic score grade IV for the study knee
* Change in physical therapy/occupational therapy for the knee within the last 3 months
* Treatment with nonsteroidal antiinflammatory drugs (NSAIDs) (including topical agents for the study knee) during the last week (or 5 half-lives of the drug, whichever is longer) prior to baseline visit
* Treatment with non-NSAID topicals such as capsaicin for the knee within the last 3 days
* Intra-articular injection with corticosteroids in the study knee within the last 3 months
* Use of systemic steroids (excluding inhalation steroids) within the last 3 months
* Intra-articular injections with hyaluronic acid in the study knee within the last 9 months
* Treatment with glucosamine/chondroitin sulfate within the last 3 months
* Treatment with pain relievers except for paracetamol up to 4g/day
* Treatment with anticoagulant (except for acetylsalicylic acid max. 325 mg/day)
* Arthroscopy or any other surgical procedure in the study knee within the last 12 months
* Planned arthroscopy or any other surgical procedure during the study period
* Any medical condition which in the opinion of the investigator makes the patient unsuitable for inclusion (e.g. severe progressive chronic disease, malignancy, bleeding disorder, fibromyalgia)
* Systemic active inflammatory condition or infection, such as Rheumatoid arthritis, inflammatory arthritis, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, gout/acute pseudogout or any other connective tissue disease
* Septic arthritis in the study knee within the last 3 months
* Active skin disease or infection in the area of the injection site
* Significant venous or lymphatic stasis present in the legs
* Pregnant or breast-feeding woman or woman of child-bearing potential not practicing adequate contraception
* Subjects that in the opinion of the investigator are unsuitable for inclusion (e.g. subjects not likely to avoid other therapies, subjects not likely to stay in the study during the whole study period, or subjects likely to be unreliable)
* Concurrent participation in any other clinical study or participation within the preceding 30 days

Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No